Press Releases
🌏 NMPA Page 4NMPA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Access critical pharma & biotech press releases. Stay ahead on drug approvals, clinical trials, M&A, and regulatory updates impacting global markets.
Showing 37–48 of 97 articles
Immunic Appoints Dr. Michael Panzara as Chief Medical Officer to Lead Vidofludimus Calcium Development
Zhengye Biotechnology Reports Fiscal 2025 Financial Results for Veterinary Vaccine Business
Akso Health Group Launches Brain-Computer Interface R&D Program Targeting Neurotechnology Market
Evofem Biosciences Secures Exclusive SOLOSEC Distribution Agreement for Sub-Saharan Africa Market
PSG 2026 Specialty Drug Benefits Report: Cost Management Remains Top Priority as Coverage Strategies Challenge Payers
WuXi AppTec Reports 39.4% Revenue Growth in Q1 2026, Backlog Reaches RMB 59.77 Billion
IMG Pharma Acquires Matsumoto Pharmaceutical in Strategic Japanese Market Expansion Deal
Aquestive Therapeutics Faces Class Action Lawsuit Over Anaphylm Drug Approval Timeline Claims
BioMarin Completes $3 Billion Acquisition of Amicus Therapeutics, Expands Rare Disease Portfolio with Galafold and Pompe Therapies
Eyebright Medical Reports Strong 2025 Results Driven by Innovation and Global Expansion
PMC Organometallix Announces 10-25% Price Increases Across All Product Lines Effective May 2026
Sunnybrook Health Sciences Centre Receives $41 Million Investment to Expand Clinical Trials Infrastructure in Canada